Acacia Research (ACTG)
Quick facts
| Ticker | ACTG (NASDAQ) |
|---|
Marketed products
- Barhemsys · Neuroscience
Barhemsys works by blocking dopamine receptors in the brain.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: